Key NAFLD/NASH Studies Influencing My Practice Following AASLD 2019

November 8-12, 2019; Boston, Massachusetts
Listen to downloadable audio from a live Webinar reviewing the most clinically relevant new NAFLD/NASH data. Topics include global disease burden, treatments in development, and disease monitoring.
Zobair Younossi Headshot
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Format: Audio (.mp3)
File Size: 10.3 MB
Released: November 22, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

Related Content

Download free expert-authored slides to get up-to-date on Asia-Pacific considerations regarding HCC in the setting of hepatitis B.

Grace LH Wong, MD Released: June 10, 2021

Clinical Care Options (CCO) expert Dr Grace LH Wong discusses Asia-Pacific considerations in caring for patients with HBV at risk for HCC

Grace LH Wong, MD Released: June 8, 2021

Expert Clinical Care Options (CCO) commentary on racial disparities in HBV care among Caribbean immigrant communities in the US

Patricia D. Jones, MD, MSCR Released: June 7, 2021

Clinical Care Options (CCO) expert Dr. Norah Terrault on HCC risk scores to inform personalized HCC surveillance in patients with chronic hepatitis B

Norah Terrault Headshot Norah Terrault, MD, MPH Released: June 4, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue